首页> 外文OA文献 >190P Observational cohort study of 1st line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Sub-group analysis by the Glasgow Prognostic Score (GPS)

【2h】

190P Observational cohort study of 1st line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Sub-group analysis by the Glasgow Prognostic Score (GPS)

机译：190P展示队伍三线贝伐单抗与化疗联合转移结直肠癌（HGCSG0802）的观察队列研究（HGCSG0802）：由Glasgow预后评分（GPS）分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
T. Sasaki; S. Yuki; Y. Kawamoto; K. Harada; T. Meguro; T. Miyagishima; M. Nakamura; A. Sato; I. Iwanaga; M. Tateyama; K. Hatanaka; K. Eto; H. Okuda; O. Muto; M. Abe; A. Oba; S. Kato; K. Miyashita; Y. Sakata; Y. Komatsu;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. An observational cohort study of bevacizumab and chemotherapy in metastatic colorectal cancer patients: safety and efficacy with analysis by age group [J] . Tahover Esther, Hubert Ayala, Temper Mark, Targeted oncology . 2015 ,第1期

机译：贝伐珠单抗和化疗对转移性结直肠癌患者的观察性队列研究：安全性和有效性（按年龄分组）
2. The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of K-ras mutation status: analysis of a phase III study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancer. [J] . Hurwitz HI, Yi J, Ince W, The oncologist . 2009 ,第1期

机译：贝伐单抗在转移性结直肠癌中的临床获益与K-ras突变状态无关：贝伐单抗联合化疗治疗未经治疗的转移性结直肠癌的III期研究的分析。
3. Prospective observational cohort study of bevacizumab combined with paclitaxel as the first-or second-line chemotherapy for locally advanced or metastatic breast cancer (Study JBCRG-C05: B-SHARE) [J] . Kashiwaba M., Yamamoto Y., Yamashiro H., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2018 ,第期

机译：贝伐单抗与紫杉醇相结合的前瞻性观察队列研究作为局部晚期或转移性乳腺癌的第一或二线化疗（研究JBCRG-C05：B份）
4. Pesticide Use and Lung Cancer Risk in the Korea National Cancer Center Community- Based Cohort Study: A Propensity Score Matching Analysis [C] . Byungmi Kim, Eunyoung Park, Jinsun Kim, Joint annual meeting of the International Society of Exposure Science and the International Society for Environmental Epidemiology . 2018

机译：韩国国家癌症中心社区队列研究中的农药使用和肺癌风险：倾向得分匹配分析
5. P-152Observational Cohort Study of 1st line Bevacizumab Combined with Chemotherapy in Metastatic Colorectal Cancer (HGCSG0802): Sub-group Analysis by the Glasgow Prognostic Score (GPS) [O] . T. Miyagishima, S. Yuki, H. Nakatsumi, -1

机译：P-152一线贝伐单抗联合化疗治疗转移性结直肠癌（HGCSG0802）的观察性队列研究：通过格拉斯哥预后评分（GPS）进行的亚组分析
6. The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation [O] . Seiichiro Mitani, Hiroya Taniguchi, Keiji Sugiyama, 2019

机译：Glasgow预后评分对BRAF v600E突变转移结直肠癌患者的二线化疗存活

190P Observational cohort study of 1st line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Sub-group analysis by the Glasgow Prognostic Score (GPS)

著录项

相似文献

相关主题

期刊订阅